Study of serum and salivary levels of proinflammatory cytokines, potential biomarkers in the diagnosis of oral squamous cell carcinoma

Academic Journal of Cancer Research

Volumn 4, Issue 2, 2011, Pages 47-55

  Hamad, Abdul Wahab R ^a   Gaphor, Shanaz M ^b   Shawagfeh, Maissa T ^a   Al Talabani, Nazar G ^b  

^a AL BALQA APPLIED UNIVERSITY   (Jordan)

^b UNIVERSITY OF SULAIMANI   (Iraq)

Author keywords

Il 1; Il 6; Il 8 GM CSF

Indexed keywords

GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 1ALPHA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER EPIDEMIOLOGY; CARCINOGENESIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE MARKER; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOREGULATION; MALE; MOUTH SQUAMOUS CELL CARCINOMA; PATHOGENICITY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SALIVA LEVEL;

EID: 84862066996     PISSN: 19958943     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Silverman, S.J.R., 2001. Demographics and occurrence of oral and pharyngeal cancers. The outcomes, the trends, the challenge. Journal American Dental Association, 132: 75-115.
2. Neville, B.W., D.D. Damm, C.M. Allen, 2002. Oral and Maxillofacial Pathology. 2nd ed. Phila. PA: Saunders, pp: 337-369.
3. Williams, K., 1997. Interactions of polyamines with ion channels. Biochemistry J., 325(pt2): 289-297.
4. Swango, P.A., 1996. Cancer of the Oral Cavity and Pharynx in the United States: An epidemiologic overview. J. Public Health Dental. 56: 309-318.
5. Bhatti, N., M.C. Downer and J.S. Bulman, 1995. Public Knowledge and attitudes on oral cancer: a pilot investigation. Journal Institute Health Education, 32: 112-117.
6. John, M.A.R., Li. Yang, X. Zhou, P. Denny and Chin Ming Ho, 2004. Interleukin 6 and Interleukin 8 as potential biomakers for oral cavity and oropharyngeal squamous cell carcinoma. Archives Otolaryngol Head Neck Surgery. 130: 929-935.
7. Young, M.R., M.A. Wright, Y. Lozano, M.M. Prechel and G.J. Petruzzelli, 1997. Increased recurrence and metastasis in patients whose primary head and neck squamous cell carcinomas secreted granulocyte-macrophage colony-stimulating factor and contained CD34 + natural suppressor cells. International Journal Cancer, 20; 74(1): 69-74.
8. Gleich, L.L., P.W. Biddinger, F.D. Duperier and J.L. Gluckman, 1997. Tumor angiogenesis as a prognostic indicator in T2-T4 oral cavity squamous cell carcinoma: a clinical- pathological correlation. Head Neck, 19: 276-280.
9. Pak, A.S., MA. Wright, J.P. Mattews, S.L. Collins, G.J. Petruzelli and M.R.I. Young, 1995. Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34+ cells which suppress immune functions within cancer that stimulating factor. Clinical Cancer Res., 1: 95-103.
10. Vlock, D.R., B. Arnold, J. Humpierres, D.R. Schwartz et al. 1992. Serial studies of autologous antibody reactivity to squamous cell carcinoma of head and neck. Cancer Immunology and Immunotherapyapy, 34: 329-336.
11. Chen, Z., P.S., Malhotra and G.R. Thomas 1999. Expression of Proinflammatory and Proangiogenic Cytokines in Patients with Head and Neck Cancer. Clinical Cancer Res., 5: 1369-1379.
12. Chen, Z., I. Colon, N. Ortiz, M. Callister Dong, M.Y. Pegram, O. AroSarena S. Strome and C. Van Waes, 1998. Effects of interleukin-1 alpha, interleukin-1 receptor antagonist and neutralizing antibody on proinflammatory cytokine expression by human aquamous cell carcinoma lines. Cancer Res., 15; 58(16): 3668-76.
13. Woods, K.V., K.A. Storthz, G.L. Clayman, G.M. Francis and E. A. Grimm, 1998a. Interleukin-1 regulates interleukin-6 secretion in human oral squamous cell carcinoma in vitro: Possible influence of P53 but not human papilloma virus E6/E7. Cancer Res., 58(14): 3142-3149.
14. Mann, E.A., J.D. Spiro, L.L. Chen and D.L. Kreutzer, 1992. Cytokine expression by head and neck squamous cell carcinoma. American J. Surgery, 164(6): 567-73.
15. Wolf, J.S., Z. Chen, G. Dong, J.B. Sunwoo, C.C. Bancroft, Capo, N.T. Yeh, N. Mukaida and C.V. Waes, 2001. IL (Interleukin)-l* promotes Nuclear Factor-KB and AP-1-induced IL-8 Expression, cell survival and proliferation in head and neck squamous cell carcinomas. Clinical Cancer Res., 7: 1812-1820.
16. Gallo, O., A.M. Gori, M. Attanasio, F. Martini, B. Giusti, T. Brunelli and E. Gallina, 1995. Interleukin-6 and acute phase proteins in head and neck cancer. European Archives Otorhinolaryngol., 252(3): 159-62.
17. Jablonska, E., L. Piotrowski, Z. Grabowska, 1997. Serum Levels of IL-IB, IL-6, TNF-a, STNF-RI and CRP in patients with oral cavity cancer. Pathology and Oncology Res., 3(2): 126-129.
18. Berek, J.S., C. Chung, Kaldik, I Waston and R.M. Knox, 1991. Serum interleukin-6 levels correlate with disease status in patients with epithelial ovarian cancer. American I Obstetrician Gynecol., 164: 1038-1042.
19. Blay, J.Y., J.F. Rossi, I Wijdenes, C. Menetrier-Caux T. Philip and M. Favrot, 1997. Role of interleukin-6 in the paraneoplastic inflammatory syndrome associated with renal cell carcinoma. International J Cancer, 72: 424-430.
20. Ueda, T., E. Shimada and T. UraKawa, 1994. Serum levels of cytokines in patients with colorectal cancer: possible involvement of interleukin-6 and interleukin-8 in hematogenous metastasis. J Gastroenterol., 29: 423-429.
21. Oka, M., K. Yamamoto, M. Takahashi, M. Hakozaki, T. Abe, N. Iizka, S. Hazama, K. Hirazawa, H. Hayashi, A. Tangoku, K. Hirose, T. Ishihara and T. Suzuki, 1996. Relationship between serum levels of interleukin 6, various disease parameters and malnutrition in patients with esophageal squamous cell carcinoma. Cancer Res., 56: 2776-2780.
22. Chopra, V., T.V. Dinh and E.V. Hannigan, 1998. Circulating serum levels of cytokines and angiogenic factors in patients with cervical cancer. Cancer Investigation, 16: 152-159.
23. Lissoni, P., F. Rovelli, E. Tisi, F. Brivio, A. Ardizzoia and S. Barni, 1995. Relationship between macrophage and T helper-2 lymphocyte functions in human neoplasms: neopterin, interleukin-10 and interleukin-6 blood levels in early or advanced solid tumors. Journal Biology Regulators and Homeostatic Agents, 9: 146-149.
24. Smith, C.W., G. Chenz, E. Dong and Loukinova, M. Y. Pegram, 1998. The host environment promotes the development of primary metastatic squamous cell carcinomas that constitutively expressed proinflammatory cytokines IL-1 alpha, IL-6, GM-CSF and KC. Clinical and Experiment Metastasis, 16(7): 655-64.
25. Sakamoto, K., T. Masuda, S. Mita, T. Ishiko, Y. Nakashima and M. Ogawa, 1992. Interleukin-8 is constitutively and commonly produced by various human carcinoma cell lines. International J. Clinical and Laboratory Res., 22: 216-219.
26. Scheibenbogen, C., T. Mohler, J. Haefele, W. Hunstein and Keilholzu, 1995. Serum interleukin-8 (IL-8) is elevated in patients with metastatic melanoma and correlates with tumor load. Melanoma Res., 5: 179-181.
27. Chopra, V., T.V. Dinh and E.V. Hannigan, 1997. Serum levels in interleukins, growth factors and angiogenin in patients with endometrial Journal of Cancer Research and Clinical Oncol., 123: 167-172.
28. Yamamura, M.R., Modlin, J. Ohmen and R. Moy, 1993. Local expression of anti-inflammatory cytokines in cancer. J. Clinical Investigation, 91: 1005-1010.
29. Cohen, R.F., J. Contrino, J.D. Spiro, E.A. Mann, L.L. Chen and D.L. Kreutzer, 1995. Interleukin-8 exoression by head and neck squamous cell carcinoma. Archives of Otolaryngol Head Neck Surgery, 121(2): 202-9.
30. Richard, B.L., R.J. E isma, J.D. Spiro, R.L. Lindquist and D.L. Kreutzer, 1997. Coexpression of interleukin-8 receptors in head and neck squamous cell carcinoma. American J. Surgery, 174(5): 507-12.
31. Eisma, R.J., J.D. Spiro and D.L. Kreutzer, 1999. Role of angiogenic factors: Coexpression of interleukin-8 and vascular endothelial growth factor in patients with head and neck squamous carcinoma. Laryngoscope, 109(5): 687-93.
32. Watanabe, H., M.I. Wase, M. Ohashi and M. Nagumo, 2002. Role of interleukin-8 secreted from human oral squamous cell carcinoma cell lines. Oral Oncol., 38(7): 670-9.
33. Woods, K.V., A.E.I. Naggar, G.L. Clayman and E.A. Grimm, 1998. Variable expression of cytokines in human head and neck squamous cell carcinoma cell lines and consistent expression on surgical specimens. Cancer Res., 58(14): 3132-3141.
34. Nicolaos, C.H., M. Sanghamitra, S.M. Craig and F. Mehnaaz Ali, 2005. Application of microchip assay for the measurement of C-reactive protein in human saliva. Laboratory on Chip, 5(3): 261-269.